Загрузка...
Preclinical activity of melflufen (J1) in ovarian cancer
Ovarian cancer carries a significant mortality. Since symptoms tend to be minimal, the disease is often diagnosed when peritoneal metastases are already present. The standard of care in advanced ovarian cancer consists of platinum-based chemotherapy combined with cytoreductive surgery. Unfortunately...
Сохранить в:
| Опубликовано в: : | Oncotarget |
|---|---|
| Главные авторы: | , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Impact Journals LLC
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5312315/ https://ncbi.nlm.nih.gov/pubmed/27528037 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11163 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|